chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pain in arm; prevented sleep; nausea; tiredness; loss of appetite; This is a spontaneous report from a contactable consumer, the patient. A 44-years-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the right arm on 01May2021 at 15:30 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not receive any medication within two weeks of vaccination.  Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02May2021 at 00:00 the patient experienced pain in arm, prevented sleep, nausea, tiredness and loss of appetite. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event pain in arm, prevented sleep, nausea, tiredness and loss of appetite were recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Tonsillar and occipital Lymph node moderate swelling. Difficulty Swallowing. Stiffness in head and neck. Profound fatigue. methylprednisoLONE (Medrol, Pak,) 4 mg tablet and azithromycin (Zithromax Z-Pak) 250 MG tablet mono test negative After 5 days on medications nodes size reduced, tenderness, stiffness, fatigue remain, but overall improved.
On day 2 post vaccination (10/4/21), I woke in the morning as usual. The left eye had the sensation of heaviness that progressed throughout the day. By the end of the day I began to notice the feeling of pins and needles on the skin surrounding the eye (on the brow bone and radiating below). I also noticed my vision had become some what blurry.  I also had a low grade fever and generally did not feel well. The symptoms continued for another two days getting gradually worse.  I made an appointment with my eye Doctor. She determined that I had developed Herpes Zoster Opthalmicus (re-activation of the varicella virus). She stated that this was likely caused by immunization as I am young and not in an immunocompromised state. Treatment of Acyclovir 800mg, Five times daily was started and follow up in one week.
7.5 x 8.5cm area on lt anterior thigh site of inj, round, sl raised, warm;
Bells Palsy   Put on steroid by primary care doctor   Affected right side of face
This spontaneous report as received from a medical assistant (reported also as administrator) refers to a patient of an unknown age and gender. The patient's concomitant therapies, concurrent conditions and medical history were not reported. On 05-SEP-2017, the patient was vaccinated with ROTATEQ orally, lot # L048854, expiration date 31-AUG-2017 (concentration and dose were not reported). On 05-SEP-2017, the patient was vaccinated with expired product. No adverse effects were reported. The outcome of the event was not reported.
No additional AE reported.; an adult dose of VAQTA was administered to an 11 year old pediatric patient; This spontaneous report was received from a nurse practitioner (N.P.), concerning a 11-year-old patient of unknown gender. Information regarding the patient's medical history, concurrent conditions and concomitant therapies was not provided.  On 17-JUL-2022, an adult dose of hepatitis A vaccine, inactivated (VAQTA) 50U/1.0ml prefilled syringe intramuscular injection, lot number U022161, expiration date reported as 14-JAN-2022, was administered to the pediatric patient as directed to prevent hepatitis A infection (product administered to patient of inappropriate age). Lot number U022161, is an invalid lot number for hepatitis A vaccine, inactivated (VAQTA). Lot number U022161 does not match any Company product as confirmed by Lot Verification team, (strength, dose, route of administration, and anatomical location were not provided).   No additional adverse event was reported.
Severe arm pain, Extremely hot in my entire upper arm and moving to lower area of arm,, swollen 4 times it's normal size,  Red and Pink, itching,  Arm feels tight, tingling and numb. My arm is worse today than yesterday. Bad headache,  low grade fever, achy all over, Extremely fatigued,
Patient falsified DOB when registering for vaccination. Guardian consented to the vaccination. Department of Health verified with statistical records patient's actual DOB which made the vaccine a contraindication.  No known adverse reactions noted.
3 days p/vax pt described discomfort to pain from shoulder @ site of inject to neck & down middle of back-some discomfort also in hands, joints & back of knees;
Patient's arm was sore after vaccination.  The next morning, she awoke and could not lift her arm above her waist.  She went to her primary doctor and was told it would work out.  She went back to the doctor the following day as it had not improved.  The doctor examined her, explained to her that sometimes vaccines are not given in the correct spot and can cause issues.  Upon examination, it was determined that the vaccination site was in the appropriate location. He thought the pain in her arm may have been associated with shingles according to the patient.  He referred her to her arthritis specialist who also examined the patient.  He assessed her as having a rotator cuff injury and has ordered a course of physical therapy for the patient despite the patient not having any knowledge of injuring herself.
Tingling that started in distal extremities- bilaterally, then moved to thighs, upper legs, and arms the following day, and a day later, face and tongue Also has had momentary muscle "lag" or weakness in eyelids or legs
This spontaneous report as received from a healthcare worker refers to a patient of unknown age and gender. On 04-SEP-2014 the patient was vaccinated with an expired dose of M-M-R II lot # H015833, expiration date: 24-AUG-2014, 0.5 ml, subcutaneous. No adverse effects were reported. Additional information has been requested.
This spontaneous report was received from the patient's mother refers to her son of unknown age. Patient's concurrent conditions and medical history were not reported. On 14-MAY-2008 the patient was vaccinated with hepatitis b vaccine (manufacturer unknown) (dose, route of administration and lot # were not reported). Concomitant therapies included DTAP, IPV (unspecified) and hib conj vaccine (unspecified carrier). On an unknown date the patient experienced vomiting, diarrhoea and fever of 103F. After this, the patient spoke with his physician. The outcome of the events was unknown. Additional information has been requested.
1. Diarrhea - started after shot 1/12/10 2. Elevated INR 5.1 - started 1/29/10 3. Acute rhabdomyolysis w/elevated CPK - 2/5/10
This case was reported by a other health professional via call center representative and described the occurrence of muscle pain in a 35-year-old female patient who received BOOSTRIX (batch number EY273, expiry date 18th March 2019) for prophylaxis. On 22nd March 2019, the patient received BOOSTRIX. In March 2019, less than a week after receiving BOOSTRIX, the patient experienced muscle pain, shoulder pain and neck pain. On 22nd March 2019, the patient experienced expired vaccine used. On an unknown date, the outcome of the muscle pain, shoulder pain, neck pain and expired vaccine used were unknown. It was unknown if the reporter considered the muscle pain, shoulder pain and neck pain to be related to BOOSTRIX. Additional details were provided as follows: The health care professional reported that she inadvertently administered an expired dose of BOOSTRIX to a patient, which was already expired on 18th March 2019. The reporter stated that the patient complained of muscle aches, shoulder and neck pain.
Pt stated starting 3/15/3/16, her left arm started swelling and turning red. Pt states there was an oval shaped nodule under the injection site. Pt stated swelling lasted until 3/17, still some swelling today but mostly gone. There is still the oval shaped nodule around the injection site.
Patient was brought to ER after developing eye, lip, and tongue swelling. Patient apparently received flu shot in AM. Patient received a dose of SOLU MEDROL IV followed by po prednisone. Patient did not have a history of allergy to the flu shot and had received in past w/o complications.
Initial unsolicited report received from a rheumatologist via other company (Pfizer) (manufacturer report number: 2017336899) on 05-SEP-2017. This case involves a 63-year-old female patient who was vaccinated with a dose of TETANUS TOXOID (batch number, expiry date, dose, dose in series, route and site of administration were not reported) on an unknown date. Patient's medical history and concomitant medication were not reported. On 01-AUG-2017, following vaccination, it was reported that patient developed allergy to tetanus. Lab tests and corrective treatment were not reported. Outcome of the event was not reported. List of documents held by sender: none.
The day after my first dose I could not walk. My left knee and left calf is very swollen. I cannot straighten my left leg or walk on it. It?s bent and I am in excruciating pain. All of my joints feel bruised and hurt.
Reports the following symptoms after receiving the Flu and SHINGRIX vaccine on 9/28/18: Body aches, joint pains, chills, fever of 99.9F, dry throat and patient reports it does feel like throat was swelling, no painful swallowing or no difficulty swallowing, dry eyes, dizziness and does feel very weak, and was not able to move the left arm due to pain. Patient also reports tiny white blisters in the "rim" of the eyelids the next day. Some eye pain. Took TYLENOL for symptoms.
Sudden and complete loss of vision in left eye for about 1 minute followed immediately by sudden and complete recovery of vision. No other symptoms. Lovastatin increased from 20mg/day to 40mg/day. Aspirin increased from 81mg every other day to 81mg every day. I  have not subsequently experienced any symptoms to date.
fatigue; brain fog; depressed; anxious; double vision; dizziness; This is a spontaneous report from a contactable Nurse (mother) reported for her son. A 46-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection, lot Number unknown, expiration date unknown), 1st dose, via an unspecified route of administration on 16Feb2021 as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Caller which was a mother of patient was inquiring about the side effects which had been experienced by her 46-year-old son since receiving the first dose of the vaccine. She stated that 1-2 weeks after the first dose patient began having fatigue and brain fog. Gradually since then he has become depressed and anxious. She also mentions double vision and dizziness. Caller has questions regarding if these side effects have been reported. Patient inquired about the best way patient can stay updated on the vaccine as new information comes out. The outcome of all the events was unknown.  Information on the lot/batch number has been requested.
3 hours after vaccination arm felt heavy and patient felt fatigued. The next day arm was extremely painful could not lift it and felt tired. In the afternoon she called the pharmacy stating that she was weak nauseous and had chills and a severe headache. I instructed her to go to urgent care.
A non-serious spontaneous report of administration of expired vaccine was received from a health professional concerning a five-year-old male. Neither past medical history nor concomitant medications were reported for this patient. The FLUMIST expired on 22-Dec-2010. On 27-Dec-2010, the patient received expired FLUMIST. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event is considered resolved. Additional information was received on 24-Mar-2011 which confirmed that the patient did not report any adverse events following administration of expired FLUMIST. This information was incorporated into the narrative.
arm soreness for the past 7 days. 12/31/2020 had red itching rash at injection site. today rash still there with continued muscle soreness, including neck soreness now.
Client developed redness, warmth, pain, and hardness to site of vaccine which resolved without incident.
I developed slowly progressive lower abdominal pain, cramping, and then difficulty with urination and dysuria, eventually to the point of seeking medical care for the pain and inability to urinate.
Woke up 5/31 feeling congestion and sore throat.  I had body aches and I had low pulse oximeter readings for about 4 days.  I experienced shortness of breath, but never asthma.  By 6/2 coughing and headache developed.  Morning of 5/31 I tested with an At Home COVID 19 Antigen test with a strong positive.  6/5 and 6/6, also positive, but weaker.  6/7 Was first negative test.  Telemedicine with doctor on 5/31.  Doctor prescribed Paxlovid.  Still experiencing a little tickling cough.
Began experiencing chills; Fever of 101.7; Fatigue/exhaustion; Nausea; This is a spontaneous report from a non-contactable consumer, the patient. A 45-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 59267-1000-01) via an unspecified route of administration in the left arm on 03May2021 at 12:45 (at the age of 45-years old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included ethinylestradiol, norethisterone acetate (JUNEL), EMERGEN C IMMUNE SUPPORT, OLLY GLOWING SKIN; all for unknown indications from an unknown start date and unknown if ongoing. The patient had no known allergies. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 12Apr2021 at 11:45 (at the age of 45-years old) as a single dose for COVID-19 immunisation. On 04May2021 at 04:00, after 16 hours of the vaccination, the patient experienced chills, a fever of 101.7 (units unspecified), fatigue or exhaustion and nausea that lasted about 24 hours. The events did not result in doctors or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of events, which included treatment with OTC ibuprofen (MANUFACTURER UNKNOWN) to reduce fever and symptoms. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events, chills, a fever of 101.7 (units unspecified), fatigue or exhaustion and nausea was recovered on 05May2021.  No follow-up attempts are possible. No further information is expected.
She states she got her covid vaccine on Friday morning and only had a little site soreness on Friday night. On Saturday she noticed she had some itching to her feet and between toes, but had no rash. She felt okay on Sunday. This am she awoke and had dizziness and nausea. She reports hx of vertigo and took meclizine and called in to work and went back to bed. A few hours later she reports onset of headache, body aches and fatigued. She states she awoke from a nap and has a temp of 100.3 now. She states her dizziness has improved. She plans to see her PCP tomorrow and get a covid test at location. Records indicate that COVID test ordered on 1/25/2021, however, patient has not yet gone to have it done.
She developed a big, red, hot mark on arm which started to itch. She took Benadryl and then it went away
Migraine headache that lasted more than 48 hours. Fatigue. Rash developed at injection site.
Persistent electrical type pain,  persistent weakness of L upper extremity , and this is 5 weeks from injection date
Information has been received from a pharmacist concerning a 65-year-old female who about "one month and one week ago," approximately on 05-Aug-2007, was vaccinated subcutaneously with a 0.65 milliliter dose of Zostavax.  On approximately 29-Aug-2007, ("it is unknown when symptoms began, however for at least 2 weeks") the patient experienced pain in the arm (unspecified site) of the injection site.  The pain is experienced when the patient "reaches out".  Symptoms do not include swelling, redness, or rash.  No laboratory or diagnostic studies were performed.  The patient sought medical attention by speaking with the pharmacist.  The outcome was reported as not recovered.  No product quality complaint was involved.  No further information is available.
Patient received her two covid-19 Pfizer vaccines (first on 8/2/21 and second on 8/23/21). On Monday 8/30/21 she developed chest pain, shortness of breath, and fatigue. She was seen by her pediatrician  on Friday 9/3/21. She was noted to have shortness of breath and tachycardia. She was sent to the emergency room. A chest x-ray  and CT of the chest was performed which revealed extensive bilateral pulmonary emboli throughout the bilateral lobar arteries extending into the segmental arteries. There are multiple small solid pulmonary nodules, the largest measuring 5 mm in the superior right lower lobe. She was taken off her oral birth control pills and placed on a blood thinner (apixaban) and sent home to follow up with her PCP.
Within 24 hrs, redness, swelling, pain, burning - 3 dys later started to go down my arm - below elbow. Antibiotics on KEFLEX 500mg every 8 H.
Tested positive for covid, sore throat, headache, fever, runny nose, nasal congestion, mild chest pain
Patient received pfizer vaccine on 2/3/21, 3/3/21, and 11/2/21. Presented to ER on 5/2/22 and found to be COVID19 positive. who sustained a left femoral hip fracture after a mechanical fall at home. He was also noted to test positive for COVID in the emergency room with a noted D-dimer >20. CT angio of chest was negative for pulmonary embolism and pneumonia with noted 3.1 cm right lung nodule (this appears to be new). Ultrasound of lower extremities negative for DVT. He was noted to have acute hypoxia thought to be secondary to acute COPD exacerbation requiring oxygen. He was treated with antibiotic, steroids, and bronchodilator with noted clinical improvement and ability to be weaned to room air. He completed treatment for COPD exacerbation. Discharged on 5/13/22
No additional AE reported; patient received a dose of VARlVAX and M-M-R II that has experienced an ongoing temperature excursion; This spontaneous report was received from a medical assistant and nurse who refers to a 12-month-old (also reported as 13-month-old) female patient. The patient had no known allergies. Information regarding pertinent medical history was not provided. The patient had 2 siblings. The patient birth weight was reported as 7 lbs and 4.2 oz. On 14-MAY-2021, the patient received following vaccines (reported as concomitant): hepatitis a vaccine (reported as HEP A), pneumococcal vaccine conj 13v (crm197)(PREVNAR 13) and diphtheria vaccine toxoid (+) hib vaccine conj (tet tox) (+) pertussis vaccine acellular 5-component (+) polio vaccine inact 3v (mrc 5) (+) tetanus vaccine toxoid (PENTACEL).  On the same date, the patient was vaccinated with improperly stored: measles (+) mumps (+) rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II) lot # S039319, expiry date 04-DEC-2021, second dose, subcutaneously in the left vastus lateralis, for prophylaxis; and with varicella virus vaccine live (oka/merck) (VARIVAX) lot # T029535, expiry date 01-SEP-2022, second dose, subcutaneously in the right vastus lateralis, for prophylaxis (formulation, concentration, dose, frequency for both vaccines were not reported). Digital data logger was involved. The suspect vaccines underwent the temperature excursion, the highest temperature reported was 114.8 degrees of Fahrenheit (F), and the temperature during the time of administration was unknown. The temperature excursion started on 13-MAY-2021 at 09:15 and vaccines were not back in the proper range (time frame of excursion was reported as ongoing). There was no previous temperature excursion. Patient's parents were notified at vaccines excursion and they did not report any adverse events the patient experienced (no adverse event). The patient would be re-vaccinated within appropriate timeframe. No product quality complaint (PQC) was involved.
Congestion in the head still; Felt like she had a cold; Feeling more tired than usual; Headache; Contracted covid after 1st dose; Started to get sick; coughing; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Contracted covid after 1st dose), ILLNESS (Started to get sick), COUGH (coughing), HEAD DISCOMFORT (Congestion in the head still) and NASOPHARYNGITIS (Felt like she had a cold) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetic and Defibrillator/pacemaker insertion.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced COVID-19 (Contracted covid after 1st dose), ILLNESS (Started to get sick), COUGH (coughing), NASOPHARYNGITIS (Felt like she had a cold), FATIGUE (Feeling more tired than usual) and HEADACHE (Headache). On an unknown date, the patient experienced HEAD DISCOMFORT (Congestion in the head still). At the time of the report, COVID-19 (Contracted covid after 1st dose), ILLNESS (Started to get sick), COUGH (coughing), HEAD DISCOMFORT (Congestion in the head still), NASOPHARYNGITIS (Felt like she had a cold), FATIGUE (Feeling more tired than usual) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included lots of unspecified medications.  No treatment medications were reported.